Cragg, 2005, Curr Dir Autoimmun, 8, 140, 10.1159/000082102
Einfeld, 1988, EMBO J, 7, 711, 10.1002/j.1460-2075.1988.tb02867.x
Stashenko, 1981, Proc Natl Acad Sci U S A, 78, 3848, 10.1073/pnas.78.6.3848
Beers, 2010, Semin Hematol, 47, 107, 10.1053/j.seminhematol.2010.01.001
Li, 2003, J Biol Chem, 278, 42427, 10.1074/jbc.M308802200
Beers, 2010, Blood, 115, 5191, 10.1182/blood-2010-01-263533
Giles, 2003, Br J Haematol, 123, 850, 10.1046/j.1365-2141.2003.04683.x
Manshouri, 2003, Blood, 101, 2507, 10.1182/blood-2002-06-1639
Taylor, 2008, Curr Opin Immunol, 20, 444, 10.1016/j.coi.2008.05.011
Uchida, 2004, J Exp Med, 199, 1659, 10.1084/jem.20040119
Lefebvre, 2006, J Immunother, 29, 388, 10.1097/01.cji.0000203081.43235.d7
Boye, 2003, Ann Oncol, 14, 520, 10.1093/annonc/mdg175
Robak, 2010, J Clin Oncol, 28, 1756, 10.1200/JCO.2009.26.4556
Robak, 2009, Drugs, 69, 2415, 10.2165/11319270-000000000-00000
Onrust, 1999, Drugs, 58, 79, 10.2165/00003495-199958010-00009
Golay, 2000, Blood, 95, 3900, 10.1182/blood.V95.12.3900
Zhou, 2008, Oncologist, 13, 954, 10.1634/theoncologist.2008-0089
Byrd, 2002, Blood, 99, 1038, 10.1182/blood.V99.3.1038
Pedersen, 2002, Blood, 99, 1314, 10.1182/blood.V99.4.1314
Teeling, 2006, J Immunol, 177, 362, 10.4049/jimmunol.177.1.362
Wilson, 2000, Semin Oncol, 27, 30
Stolz, 2009, Leuk Lymphoma, 50, 873, 10.1080/10428190902878471
Cartron, 2002, Blood, 99, 754, 10.1182/blood.V99.3.754
DallʼOzzo, 2004, Cancer Res, 64, 4664, 10.1158/0008-5472.CAN-03-2862
Hatjiharissi, 2007, Blood, 110, 2561, 10.1182/blood-2007-01-070656
Kim, 2006, Blood, 108, 2720, 10.1182/blood-2006-01-009480
Racila, 2008, Clin Cancer Res, 14, 6697, 10.1158/1078-0432.CCR-08-0745
van Meerten, 2006, Clin Cancer Res, 12, 4027, 10.1158/1078-0432.CCR-06-0066
Golay, 2001, Blood, 98, 3383, 10.1182/blood.V98.12.3383
Weitzman, 2009, Leuk Lymphoma, 50, 1361, 10.1080/10428190903026500
Henry, 2010, Blood, 115, 2420, 10.1182/blood-2009-06-229112
Robak, 2009, Curr Med Chem, 16, 2212, 10.2174/092986709788453122
Robak, 2008, Curr Opin Mol Ther, 10, 294
Lim, 2010, Haematologica, 95, 135, 10.3324/haematol.2008.001628
Ruuls, 2008, Biotechnol J, 3, 1157, 10.1002/biot.200800110
Hutas, 2008, Curr Opin Investig Drugs, 9, 1206
Robak, 2009, Curr Opin Investig Drugs, 10, 588
van Meerten, 2010, Semin Hematol, 47, 199, 10.1053/j.seminhematol.2010.01.007
Beers, 2008, Blood, 112, 4170, 10.1182/blood-2008-04-149161
Hammadi, 2010, Onco Targets Ther, 3, 99
Coiffier, 2008, Blood, 111, 1094, 10.1182/blood-2007-09-111781
Coiffier, 2010, Br J Haematol, 150, 58, 10.1111/j.1365-2141.2010.08193.x
Wierda, 2010, J Clin Oncol, 28, 1749, 10.1200/JCO.2009.25.3187
Hagenbeek, 2008, Blood, 111, 5486, 10.1182/blood-2007-10-117671
Hagenbeek, 2009, Blood (ASH Annual Meeting Abstracts), 114, 935
Salles, 2008, Blood (ASH Annual Meeting Abstracts), 93, 234
Morschhauser, 2009, Blood (ASH Annual Meeting Abstracts), 114, 884
Salles, 2009, Blood (ASH Annual Meeting Abstracts), 114, 1704
Morschhauser, 2009, J Clin Oncol, 27, 3346, 10.1200/JCO.2008.19.9117
Negrea, 2009, Blood (ASH Annual Meeting Abstracts), 114, 3757
Morschhauser, 2010, Ann Oncol, 21, 1870, 10.1093/annonc/mdq027
Friedberg, 2009, Blood (ASH Annual Meeting Abstracts), 114, 3742
Robak, 2009, Therapy, 6, 577, 10.2217/thy.09.24
Beum, 2008, J Immunol, 181, 822, 10.4049/jimmunol.181.1.822
Du, 2009, Mol Immunol, 46, 2419, 10.1016/j.molimm.2009.04.009
Teeling, 2004, Blood, 104, 1793, 10.1182/blood-2004-01-0039
Cheson, 2010, J Clin Oncol, 28, 3525, 10.1200/JCO.2010.27.9836
Taylor, 2008, Blood (ASH Annual Meeting Abstracts), 112, 1577
Wierda, 2009, Blood (ASH Annual Meeting Abstracts), 114, 207
Robak, 2009, Haematologica, 94, 81
Wierda, 2009, Haematologica, 94, 92
Milani, 2009, Curr Opin Mol Ther, 11, 200
Goldenberg, 2009, Blood, 113, 1062, 10.1182/blood-2008-07-168146
Stein, 2004, Clin Cancer Res, 10, 2868, 10.1158/1078-0432.CCR-03-0493
Goldenberg, 2010, Leuk Lymphoma, 51, 747, 10.3109/10428191003672123
Kausar, 2009, Expert Opin Biol Ther, 9, 889, 10.1517/14712590903018837
Genovese, 2008, Arthritis Rheum, 58, 2652, 10.1002/art.23732
Robak, 2008, Curr Cancer Drug Targets, 8, 156, 10.2174/156800908783769319
Martin, 2008, Semin Hematol, 45, 126, 10.1053/j.seminhematol.2008.02.007
Campbell, 2004, J Immunother, 27, 52
Bowles, 2006, Blood, 108, 2648, 10.1182/blood-2006-04-020057
Weiner, 2010, Semin Hematol, 47, 115, 10.1053/j.seminhematol.2010.01.011
Umana, 2006, Blood (ASH Annual Meeting Abstracts), 108, 22
Mössner, 2010, Blood, 115, 4393, 10.1182/blood-2009-06-225979
Umana, 2007, Blood (ASH Annual Meeting Abstracts), 110, 2348
Friess, 2007, Blood (ASH Annual Meeting Abstracts), 110, 2338
Niederfellner, 2009, Blood (ASH Annual Meeting Abstracts), 114, 3726
Robak, 2009, Curr Opin Investig Drugs, 10, 1383
Hayden-Ledbetter, 2003, Blood (ASH Annual Meeting Abstracts), 102, 2388
Barone, 2005, Ann Rheum Dis, 64, 159, 10.1136/ard.2003.020297
Burge, 2007, Arthritis Rheum, 56, S168
Barone, 2005, Proc Am Soc Clin Oncol, 24, 2549, 10.1200/jco.2005.23.16_suppl.2549
Hayden-Ledbetter, 2009, Clin Cancer Res, 15, 2739, 10.1158/1078-0432.CCR-08-1694
Rubbert-Roth, 2010, Curr Opin Mol Ther, 12, 115
Burge, 2008, Clin Ther, 30, 1806, 10.1016/j.clinthera.2008.10.017
